Contact Information
Company Information
Company
Scribe Therapeutics
Total Funding
120000000.0
Technologies
Sendgrid
Gmail
Outlook
Google Apps
Microsoft Office 365
Amazon AWS
Greenhouse.io
WP Engine
Vimeo
Nginx
WordPress.org
Mobile Friendly
Viewpoint
Keywords
biotechnology research
crispr
genetic medicines
gene editing
epigenetic silencing
crispr by design
molecular engineering
therapeutic targets
cardiometabolic disease
genetic therapy
in vivo editing
portfolio of treatments
off-target effects
safety
potency
pcsk9
ldl-c
genomic diseases
collaborations
biopharmaceutical
clinical development
gene therapy
chronic disease
precision medicine
potency & safety
genetics
genetic modification
crispr systems
nobel prize
innovative delivery technologies
ex vivo applications
synthetic biology
cellular biology
human health
molecular tools
biotechnology
regulatory affairs
drug development
sickle cell disease
neurological disorders
clinical trials
biomedical research
healthcare
drugs & therapeutics
gene delivery
biogenetic
molecular biology
life sciences
genetic testing
therapeutic strategies
disease management
crispr-based therapies
healthcare innovation
genome calibration
therapeutic development
patient-centric solutions
ldl cholesterol reduction
triglyceride management
genetic disease treatment
pharmaceutical collaborations
transformative healthcare
genetic therapeutics
healthcare professionals
rare diseases
personalized medicine
biotechnology partnerships
crispr technology
disease prevention
innovative therapeutics
healthcare transformation
genetic risk management
therapeutic pipeline
patient outcomes
health care
health
wellness & fitness
hospital & health care
Get Full Contact Details
Subscribe to reveal email addresses and export contacts.
View Plans